Value-based benefit design: Using a predictive modeling approach to improve compliance

Journal of Managed Care Pharmacy

Volumn 14, Issue 6 SUPPL. B, 2008, Pages

  Mahoney, John J ^a  

^a Pitney Bowes Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG;

ARTICLE; ASTHMA; COST BENEFIT ANALYSIS; COST CONTROL; DIABETES MELLITUS; DRUG COST; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH INSURANCE; HUMAN; HYPERTENSION; MANAGED CARE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PHARMACY BENEFIT MANAGER; PREDICTION; PREVENTIVE MEDICINE; SOCIOECONOMICS;

EID: 51349139540     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2008.14.s6-b.3     Document Type: Article

References (7)

1. American Diabetes Association. Direct and indirect costs of diabetes in the United States. Available at: www.diabetes.org/diabetes-statistics/ cost-of-diabetes-in-us.jsp. Accessed on January 26, 2007.
2. American Heart Association. Cardiovascular disease cost. Available ar: www.americanheart.org/presenter.jhtml?identifier=4475. Accessed on January 26, 2008.
3. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43:521-30.
4. Harris Interactive Survey. 2001.
5. Harris Interactive Survey. 2005.
6. Goldman DP, Joyce GF, Zheng Y. Prescription drug cost-sharing: associations with medication and medical utilization and spending and health. JAMA. 2007;298:61-69.
7. Chernew ME, Shah MR, Wegh A, et al. Impact of decreasing copayments on medication adherence within a disease management environment. Health Aff (Millwood). 2008;27:103-12.